Avgerinos George 4/A
4/A · Fortress Biotech, Inc. · Filed Jul 9, 2019
Insider Transaction Report
Form 4/AAmended
Avgerinos George
SVP, Biologics Operations
Transactions
- Award
COMMON STOCK, PAR VALUE $0.001
2018-12-11+400,000→ 655,170 total - Award
Options to purchase Common Stock
2019-04-17+200,000→ 200,000 totalExercise: $9.21Exp: 2023-06-04→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]400,000 shares of the Issuer's common stock owned by the Reporting Person vested on December 11, 2018, triggering the sale of 97,325 shares of the Issuer's common stock as reported on the Form 4, filed on December 13, 2018 (the "Original Form 4"). The 400,000 shares of the Issuer's common stock were inadvertently omitted from the Original Form 4.
- [F2]The options granted were fully vested on June 4, 2016. This grant was reinstated by the Issuer's Board of Directors on April 17, 2019.